nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.155	0.218	CbGbCtD
Torasemide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0991	0.139	CbGbCtD
Torasemide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0991	0.139	CbGbCtD
Torasemide—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0895	0.126	CbGbCtD
Torasemide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0824	0.116	CbGbCtD
Torasemide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0824	0.116	CbGbCtD
Torasemide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0625	0.0877	CbGbCtD
Torasemide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0416	0.0585	CbGbCtD
Torasemide—Digitalis intoxication (NOS)—Arformoterol—chronic obstructive pulmonary disease	0.0316	0.131	CcSEcCtD
Torasemide—Digitalis intoxication (NOS)—Formoterol—chronic obstructive pulmonary disease	0.0316	0.131	CcSEcCtD
Torasemide—Toxicity to various agents—Formoterol—chronic obstructive pulmonary disease	0.00666	0.0277	CcSEcCtD
Torasemide—Toxicity to various agents—Arformoterol—chronic obstructive pulmonary disease	0.00666	0.0277	CcSEcCtD
Torasemide—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.00287	0.0119	CcSEcCtD
Torasemide—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.00269	0.0112	CcSEcCtD
Torasemide—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.00254	0.0106	CcSEcCtD
Torasemide—PTGS1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00248	0.0517	CbGpPWpGaD
Torasemide—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00981	CcSEcCtD
Torasemide—Rectal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00876	CcSEcCtD
Torasemide—Rectal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00876	CcSEcCtD
Torasemide—Gout—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00848	CcSEcCtD
Torasemide—Gout—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00848	CcSEcCtD
Torasemide—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.00191	0.00797	CcSEcCtD
Torasemide—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.00189	0.00785	CcSEcCtD
Torasemide—Arthritis—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00733	CcSEcCtD
Torasemide—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00165	0.00687	CcSEcCtD
Torasemide—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00161	0.00669	CcSEcCtD
Torasemide—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00159	0.00662	CcSEcCtD
Torasemide—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00662	CcSEcCtD
Torasemide—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0015	0.00623	CcSEcCtD
Torasemide—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00606	CcSEcCtD
Torasemide—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00606	CcSEcCtD
Torasemide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00145	0.0303	CbGpPWpGaD
Torasemide—Thirst—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00591	CcSEcCtD
Torasemide—Arthritis—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00591	CcSEcCtD
Torasemide—Arthritis—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00591	CcSEcCtD
Torasemide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00589	CcSEcCtD
Torasemide—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.00581	CcSEcCtD
Torasemide—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00573	CcSEcCtD
Torasemide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00135	0.0281	CbGpPWpGaD
Torasemide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00555	CcSEcCtD
Torasemide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00132	0.0276	CbGpPWpGaD
Torasemide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00129	0.027	CbGpPWpGaD
Torasemide—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00534	CcSEcCtD
Torasemide—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00534	CcSEcCtD
Torasemide—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00523	CcSEcCtD
Torasemide—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00523	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00507	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00507	CcSEcCtD
Torasemide—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00503	CcSEcCtD
Torasemide—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00494	CcSEcCtD
Torasemide—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00494	CcSEcCtD
Torasemide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.0246	CbGpPWpGaD
Torasemide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.0246	CbGpPWpGaD
Torasemide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.0049	CcSEcCtD
Torasemide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00477	CcSEcCtD
Torasemide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.00476	CcSEcCtD
Torasemide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00109	0.0229	CbGpPWpGaD
Torasemide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00448	CcSEcCtD
Torasemide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00448	CcSEcCtD
Torasemide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00107	0.0224	CbGpPWpGaD
Torasemide—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00446	CcSEcCtD
Torasemide—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00442	CcSEcCtD
Torasemide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00105	0.022	CbGpPWpGaD
Torasemide—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00103	0.0043	CcSEcCtD
Torasemide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00423	CcSEcCtD
Torasemide—SLC12A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00096	0.0201	CbGpPWpGaD
Torasemide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000959	0.00399	CcSEcCtD
Torasemide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000959	0.02	CbGpPWpGaD
Torasemide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000958	0.00399	CcSEcCtD
Torasemide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000958	0.00399	CcSEcCtD
Torasemide—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000941	0.00392	CcSEcCtD
Torasemide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00094	0.0196	CbGpPWpGaD
Torasemide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000938	0.0039	CcSEcCtD
Torasemide—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000924	0.0193	CbGpPWpGaD
Torasemide—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000924	0.00385	CcSEcCtD
Torasemide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000915	0.00381	CcSEcCtD
Torasemide—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000906	0.00377	CcSEcCtD
Torasemide—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000905	0.00377	CcSEcCtD
Torasemide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.00376	CcSEcCtD
Torasemide—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00375	CcSEcCtD
Torasemide—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000899	0.00374	CcSEcCtD
Torasemide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000885	0.00368	CcSEcCtD
Torasemide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000884	0.00368	CcSEcCtD
Torasemide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000877	0.00365	CcSEcCtD
Torasemide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000877	0.00365	CcSEcCtD
Torasemide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000877	0.00365	CcSEcCtD
Torasemide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000877	0.00365	CcSEcCtD
Torasemide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000857	0.0179	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000856	0.0179	CbGpPWpGaD
Torasemide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000856	0.0179	CbGpPWpGaD
Torasemide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00085	0.00354	CcSEcCtD
Torasemide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000843	0.00351	CcSEcCtD
Torasemide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000842	0.00351	CcSEcCtD
Torasemide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000841	0.0035	CcSEcCtD
Torasemide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000838	0.00349	CcSEcCtD
Torasemide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000833	0.00347	CcSEcCtD
Torasemide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000827	0.00344	CcSEcCtD
Torasemide—Tension—Formoterol—chronic obstructive pulmonary disease	0.000816	0.0034	CcSEcCtD
Torasemide—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000816	0.0034	CcSEcCtD
Torasemide—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000808	0.00336	CcSEcCtD
Torasemide—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000808	0.00336	CcSEcCtD
Torasemide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000806	0.00336	CcSEcCtD
Torasemide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000794	0.00331	CcSEcCtD
Torasemide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000785	0.00327	CcSEcCtD
Torasemide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00078	0.0163	CbGpPWpGaD
Torasemide—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00077	0.00321	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000766	0.00319	CcSEcCtD
Torasemide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00317	CcSEcCtD
Torasemide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00076	0.00317	CcSEcCtD
Torasemide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.00316	CcSEcCtD
Torasemide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00076	0.00316	CcSEcCtD
Torasemide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000744	0.0031	CcSEcCtD
Torasemide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00074	0.00308	CcSEcCtD
Torasemide—Cough—Formoterol—chronic obstructive pulmonary disease	0.000726	0.00302	CcSEcCtD
Torasemide—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000726	0.00302	CcSEcCtD
Torasemide—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000724	0.0151	CbGpPWpGaD
Torasemide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000719	0.00299	CcSEcCtD
Torasemide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.00299	CcSEcCtD
Torasemide—Cough—Montelukast—chronic obstructive pulmonary disease	0.000711	0.00296	CcSEcCtD
Torasemide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00295	CcSEcCtD
Torasemide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00295	CcSEcCtD
Torasemide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00295	CcSEcCtD
Torasemide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00295	CcSEcCtD
Torasemide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00295	CcSEcCtD
Torasemide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00295	CcSEcCtD
Torasemide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000704	0.00293	CcSEcCtD
Torasemide—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000696	0.0145	CbGpPWpGaD
Torasemide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00289	CcSEcCtD
Torasemide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00289	CcSEcCtD
Torasemide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00069	0.00287	CcSEcCtD
Torasemide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00285	CcSEcCtD
Torasemide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000679	0.00282	CcSEcCtD
Torasemide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000679	0.00282	CcSEcCtD
Torasemide—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00067	0.014	CbGpPWpGaD
Torasemide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00278	CcSEcCtD
Torasemide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00278	CcSEcCtD
Torasemide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00278	CcSEcCtD
Torasemide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000665	0.00277	CcSEcCtD
Torasemide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000651	0.00271	CcSEcCtD
Torasemide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000641	0.00267	CcSEcCtD
Torasemide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00264	CcSEcCtD
Torasemide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00264	CcSEcCtD
Torasemide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000634	0.00264	CcSEcCtD
Torasemide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00063	0.00262	CcSEcCtD
Torasemide—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000622	0.013	CbGpPWpGaD
Torasemide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000618	0.00257	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000618	0.00257	CcSEcCtD
Torasemide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00255	CcSEcCtD
Torasemide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00255	CcSEcCtD
Torasemide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00061	0.00254	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000606	0.00252	CcSEcCtD
Torasemide—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000604	0.0126	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000601	0.0126	CbGpPWpGaD
Torasemide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000601	0.0025	CcSEcCtD
Torasemide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00249	CcSEcCtD
Torasemide—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000598	0.0125	CbGpPWpGaD
Torasemide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00249	CcSEcCtD
Torasemide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00249	CcSEcCtD
Torasemide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00059	0.00245	CcSEcCtD
Torasemide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000585	0.00244	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.00243	CcSEcCtD
Torasemide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00242	CcSEcCtD
Torasemide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00242	CcSEcCtD
Torasemide—Pain—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00242	CcSEcCtD
Torasemide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00242	CcSEcCtD
Torasemide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00241	CcSEcCtD
Torasemide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000568	0.00237	CcSEcCtD
Torasemide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000567	0.00236	CcSEcCtD
Torasemide—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000567	0.0118	CbGpPWpGaD
Torasemide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000564	0.00235	CcSEcCtD
Torasemide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000562	0.00234	CcSEcCtD
Torasemide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000562	0.00234	CcSEcCtD
Torasemide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000559	0.00232	CcSEcCtD
Torasemide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000556	0.00231	CcSEcCtD
Torasemide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00228	CcSEcCtD
Torasemide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00228	CcSEcCtD
Torasemide—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000545	0.0114	CbGpPWpGaD
Torasemide—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000543	0.00226	CcSEcCtD
Torasemide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00223	CcSEcCtD
Torasemide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00053	0.00221	CcSEcCtD
Torasemide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00053	0.0022	CcSEcCtD
Torasemide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00053	0.0022	CcSEcCtD
Torasemide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000527	0.00219	CcSEcCtD
Torasemide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00052	0.00216	CcSEcCtD
Torasemide—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000518	0.0108	CbGpPWpGaD
Torasemide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.00215	CcSEcCtD
Torasemide—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000506	0.0106	CbGpPWpGaD
Torasemide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000499	0.00208	CcSEcCtD
Torasemide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000494	0.00206	CcSEcCtD
Torasemide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000487	0.00203	CcSEcCtD
Torasemide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.00203	CcSEcCtD
Torasemide—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000487	0.0102	CbGpPWpGaD
Torasemide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00198	CcSEcCtD
Torasemide—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000471	0.00983	CbGpPWpGaD
Torasemide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00193	CcSEcCtD
Torasemide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00193	CcSEcCtD
Torasemide—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000462	0.00965	CbGpPWpGaD
Torasemide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00192	CcSEcCtD
Torasemide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00191	CcSEcCtD
Torasemide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000455	0.00189	CcSEcCtD
Torasemide—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000452	0.00944	CbGpPWpGaD
Torasemide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00187	CcSEcCtD
Torasemide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00187	CcSEcCtD
Torasemide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00183	CcSEcCtD
Torasemide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00182	CcSEcCtD
Torasemide—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000434	0.00907	CbGpPWpGaD
Torasemide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000432	0.0018	CcSEcCtD
Torasemide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.0018	CcSEcCtD
Torasemide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000431	0.0018	CcSEcCtD
Torasemide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00178	CcSEcCtD
Torasemide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00178	CcSEcCtD
Torasemide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00178	CcSEcCtD
Torasemide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00178	CcSEcCtD
Torasemide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00177	CcSEcCtD
Torasemide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00177	CcSEcCtD
Torasemide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00176	CcSEcCtD
Torasemide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000424	0.00176	CcSEcCtD
Torasemide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00176	CcSEcCtD
Torasemide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00174	CcSEcCtD
Torasemide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00174	CcSEcCtD
Torasemide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000416	0.00173	CcSEcCtD
Torasemide—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000412	0.0086	CbGpPWpGaD
Torasemide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000411	0.00171	CcSEcCtD
Torasemide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.0017	CcSEcCtD
Torasemide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00168	CcSEcCtD
Torasemide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000404	0.00168	CcSEcCtD
Torasemide—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000404	0.00843	CbGpPWpGaD
Torasemide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00168	CcSEcCtD
Torasemide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00168	CcSEcCtD
Torasemide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00168	CcSEcCtD
Torasemide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00167	CcSEcCtD
Torasemide—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000396	0.00827	CbGpPWpGaD
Torasemide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00165	CcSEcCtD
Torasemide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000395	0.00164	CcSEcCtD
Torasemide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00158	CcSEcCtD
Torasemide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00157	CcSEcCtD
Torasemide—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000376	0.00786	CbGpPWpGaD
Torasemide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000376	0.00156	CcSEcCtD
Torasemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000371	0.00774	CbGpPWpGaD
Torasemide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000367	0.00153	CcSEcCtD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000363	0.00758	CbGpPWpGaD
Torasemide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.0015	CcSEcCtD
Torasemide—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000358	0.00748	CbGpPWpGaD
Torasemide—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000336	0.00701	CbGpPWpGaD
Torasemide—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000335	0.00699	CbGpPWpGaD
Torasemide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00138	CcSEcCtD
Torasemide—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000328	0.00685	CbGpPWpGaD
Torasemide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.00131	CcSEcCtD
Torasemide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00124	CcSEcCtD
Torasemide—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000299	0.00624	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000296	0.00618	CbGpPWpGaD
Torasemide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00122	CcSEcCtD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.00604	CbGpPWpGaD
Torasemide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000288	0.0012	CcSEcCtD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000285	0.00596	CbGpPWpGaD
Torasemide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000279	0.00116	CcSEcCtD
Torasemide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000279	0.00116	CcSEcCtD
Torasemide—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000272	0.00569	CbGpPWpGaD
Torasemide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00111	CcSEcCtD
Torasemide—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000264	0.00552	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000264	0.00552	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00551	CbGpPWpGaD
Torasemide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00109	CcSEcCtD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00539	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00532	CbGpPWpGaD
Torasemide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00101	CcSEcCtD
Torasemide—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000243	0.00508	CbGpPWpGaD
Torasemide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00101	CcSEcCtD
Torasemide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00101	CcSEcCtD
Torasemide—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000241	0.00503	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000235	0.00492	CbGpPWpGaD
Torasemide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000978	CcSEcCtD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.0049	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000232	0.00485	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000232	0.00485	CbGpPWpGaD
Torasemide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.000964	CcSEcCtD
Torasemide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.000964	CcSEcCtD
Torasemide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.000958	CcSEcCtD
Torasemide—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000229	0.00479	CbGpPWpGaD
Torasemide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000951	CcSEcCtD
Torasemide—SLC12A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000223	0.00465	CbGpPWpGaD
Torasemide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.000909	CcSEcCtD
Torasemide—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000217	0.00453	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000212	0.00444	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00439	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00437	CbGpPWpGaD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000207	0.00433	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.00413	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000193	0.00403	CbGpPWpGaD
Torasemide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000797	CcSEcCtD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.00399	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000188	0.00394	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00392	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00387	CbGpPWpGaD
Torasemide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000761	CcSEcCtD
Torasemide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000735	CcSEcCtD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.00357	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00356	CbGpPWpGaD
Torasemide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000707	CcSEcCtD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00353	CbGpPWpGaD
Torasemide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000701	CcSEcCtD
Torasemide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000168	0.0007	CcSEcCtD
Torasemide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000696	CcSEcCtD
Torasemide—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000163	0.00341	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000163	0.00341	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000163	0.0034	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000161	0.00336	CbGpPWpGaD
Torasemide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00066	CcSEcCtD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00318	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00015	0.00313	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000148	0.00309	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000148	0.00309	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00293	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.0029	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000134	0.00279	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000132	0.00277	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000132	0.00276	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.0026	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00257	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000122	0.00255	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000121	0.00252	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000113	0.00236	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000113	0.00235	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00232	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00229	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000105	0.0022	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00217	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000102	0.00214	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00212	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.00209	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.61e-05	0.00201	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.55e-05	0.00199	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.41e-05	0.00197	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.4e-05	0.00196	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.27e-05	0.00194	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.14e-05	0.00191	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.05e-05	0.00189	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.92e-05	0.00186	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.57e-05	0.00179	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.52e-05	0.00178	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.45e-05	0.00177	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.4e-05	0.00176	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.34e-05	0.00174	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.08e-05	0.00169	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.04e-05	0.00168	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.97e-05	0.00166	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.77e-05	0.00162	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.76e-05	0.00162	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.66e-05	0.0016	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.47e-05	0.00156	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.4e-05	0.00155	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.36e-05	0.00154	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	7.28e-05	0.00152	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.26e-05	0.00152	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	7.26e-05	0.00152	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.75e-05	0.00141	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.5e-05	0.00136	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.92e-05	0.00124	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.38e-05	0.00112	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.19e-05	0.00108	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.82e-05	0.00101	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.78e-05	0.000999	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.69e-05	0.00098	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.63e-05	0.000968	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.36e-05	0.000911	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.3e-05	0.000899	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.27e-05	0.000892	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.22e-05	0.000882	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.19e-05	0.000875	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.97e-05	0.000829	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.92e-05	0.00082	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.92e-05	0.000819	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.89e-05	0.000813	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.89e-05	0.000813	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.82e-05	0.000798	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.66e-05	0.000764	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.58e-05	0.000748	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.55e-05	0.000741	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.47e-05	0.000726	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.3e-05	0.000689	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.1e-05	0.000648	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.83e-05	0.000591	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.75e-05	0.000574	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.71e-05	0.000567	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.56e-05	0.000535	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.53e-05	0.000529	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.53e-05	0.000528	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.0005	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.36e-05	0.000493	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000483	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.29e-05	0.000478	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.26e-05	0.000472	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000445	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.11e-05	0.00044	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.09e-05	0.000436	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.000431	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.06e-05	0.000431	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.92e-05	0.000402	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.9e-05	0.000397	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.88e-05	0.000393	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.78e-05	0.000371	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.75e-05	0.000366	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.73e-05	0.000362	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.000341	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.63e-05	0.00034	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.59e-05	0.000331	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.000327	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.56e-05	0.000325	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000323	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.46e-05	0.000304	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.45e-05	0.000302	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.43e-05	0.000298	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.000289	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.33e-05	0.000278	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.000263	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-05	0.00022	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.00021	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	9.39e-06	0.000196	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	8.98e-06	0.000188	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.56e-06	0.000179	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.19e-06	0.000171	CbGpPWpGaD
